español

Publications about Restenosis

  • Silvestre C, Fernandez P, Mansego ML, van Tiel CM, Viana R, Anselmi CV, Condorelli G, de Winter R, Martin –Fuentes P, Solanas-Barca M, Civeira F, Focaccio A, de Vries CJM, Chaves FJ, Andres V. Genetic Variants in CCNB1 Associated With Differential Gene Transcription and Risk of Coronary In-Stent Restenosis. Circulation: Cardiovascular Genetics. 2014; 7: 59-70.

  • Silvestre C, Fuster JJ, Molina P, Andrés V. Targeting cell cycle regulators in the diagnosis and treatment of atherosclerosis and restenosis: Emerging topics, current limitations and future directions. Nat Rev Cardiol (cnic Edition) (2010) 7:35-40
  • Caixeta A. & Weisz G. Restenosis and Gene Polymorphisms. Cardiology 2009;112:260–262
  • Koch W, Kastrati A, Schomig A, Mehilli J, Tiroch K, Bottiger C. P27 and P53 gene polymorphisms and restenosis following coronary implantation of drug-eluting stents. Cardiology, 2009;112(4):263-9.
  • Gonzalez JM & Andrés V. Cytostatic gene therapy for occlusive vascular disease. April 2006, Vol. 16, No. 4 , Pages 507-522
  • Kubicek M, Sanz-Gonzalez S M, Verdeguer F; Andres, V, Proteomics to Identify Novel Biomarkers and Therapeutic Targets in Cardiovascular Disease. July 2004 Letters in Drug Design & Discovery;Jul2004, Vol. 1 Issue 3, p237

© 2013 Fina Biotech. Madrid. Tel +34 917 991 564 info@finabiotech.es

Enlaces a redes sociales